Construction

Construction is a biotechnology company focused on the intersection of generative artificial intelligence and protein engineering. The company leverages advanced computational models to design novel proteins with specific therapeutic functions, aiming to address unmet medical needs across various disease areas. By integrating high-throughput experimental validation with its AI platform, Construction seeks to accelerate the drug discovery process and create highly optimized biologic candidates. The firm operates primarily in a stealth or early-stage capacity, focusing on building its core technology stack and initial pipeline programs.